Low-temperature sterilization of Novelia® eye drops vials: feasibility, content-container interactions and functional impact

3 October 2025

M. Ben Reguiga, L. Bourgue, P. Trouiller, Y. Yemi, F. Haldin
Centre Hospitalier de Mayotte, 97600 Mamoudzou, Mayotte, France

Introduction
Novelia® eye drops vials (NADV) are supplied in sterile batches of 28 units. Once opened, the batch sterility is not maintained unless used immediately under aseptic conditions. The aim of this study was to investigate the feasibility of low-temperature sterilization (LTS) of NADVs, its effectiveness, the presence of residues of the sterilizing agent (hydrogen peroxide or H2O2), the impact of LTS on the content-container interaction and its impact on the functionality of NADVs.

Materials and methods
New NADV (NEMERA) were packed in double layer of Ultra® pouches (AMCOR) and subjected to 2 types of LTS cycles (Stericool, Getinge): rapid cycle (H2O2 59%, 31 min; n=3) and standard cycle (H2O2 82%, 48 min; n=3). Following sterilization, the residual H2O2 level was measured in the double pouches of the NADVs using a Draëger X-AM 5100 probe. The inside of the NADVs was then washed with 1mL H2O. The H2O2 present in this extract was assessed by a semi-quantitative measurement using MQuant® strips (0-25ppm, Supelco). The interaction of NADV with the sterilizing agent (H2O2) and the possibility of organic matter release was assessed by quantifying Total Organic Carbon (TOC): 10mL of 0.9% NaCl was introduced into sterilized (rapid cycle) and non-sterilized (n=3/modality) NADVs, stored for 28 days at room temperature, then the TOC of the contents was analyzed in accordance with standard NF EN 1484 (Shimadzu TOC analyzer, linearity 0.5-10 mg/L). Maintenance of the sterile state was assessed by a sterility test (European Pharmacopoeia 2.6.1) at 3 and 6 months post-sterilization. To study the impact of LTS on the ability of NADVs to remain sterile once opened, sterilized VNTs were prepared under aseptic conditions and loaded with BSS (Balanced Salt Solution, Alcon) and stored at 2-8°C, 25°C or warm conditions (32°C-35°C): 2 drops of each solution are extracted each day and incubated in Trypticase Soya and Thioglycolate broths, at day 7, 14, 21 and 28.

Results
Hydrogen peroxide residues persisted in the NADV with the standard cycle (0.5 to 2ppm extractable and 0.1 to 2.3 ppm measurable), while it was not the case with the rapid cycle ([H2O2]< detection limit): the rapid cycle was retained for the rest of the study. Assessment of TOC with and without sterilization showed no release of organic matter after sterilization. The sterility test showed that the sterile state of NADV packaged in double sachets was maintained for at least 6 months. Finally, the sterilized and BSS-loaded NADVs stored under different temperature conditions retained their functionality, with the contents remaining sterile for at least 28 days.

Conclusion
NADVs can be sterilized by LTS without any risk of residual hydrogen peroxide and without releasing organic matter from the container, maintaining a sterile state for at least 6 months and without affecting their functional characteristics.

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data